For which cancers might patients benefit most from expedited symptomatic diagnosis? Construction of a ranking order by a modified Delphi technique

Table 2 Median Likert responses of statements that expedited symptomatic cancer diagnosis brings mortality or morbidity benefits

	Expedited symptomatic cancer diagnosis brings mortality benefits	Expedited symptomatic cancer diagnosis brings morbidity benefits
Strongly agree
Agree	Bladder, breast, cervix, colon, larynx, lung, melanoma, ovary, rectum, testis, uterus	Bladder, brain, colon, kidney, larynx, leukaemia, lung, myeloma, oesophagus, ovary, stomach
Undecided	Hodgkin’s disease, kidney, leukaemia, myeloma, non-Hodgkin’s lymphoma, oesophagus, ovary, stomach	Breast, cervix, Hodgkin’s disease, melanoma, non-Hodgkin’s lymphoma, pancreas, prostate, rectum, testis, uterus
Disagree	Brain, pancreas, prostate
Strongly disagree

Note: the median response for ovary and mortality was between ‘agree’ and ‘undecided’ – thus we have placed it in both cells.

ISSN: 1471-2407